Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group
- VernacularTitle:全流程药学服务在心血管内科FM35病组患者药品成本管控中的效果分析
- Author:
Wenjing CAO
1
;
Peng ZHANG
2
;
Can XIAO
1
;
Xiang LIU
1
Author Information
1. Dept. of Clinical Pharmacy，Xiangtan Central Hospital，Hunan Xiangtan 411100，China
2. Dept. of pre-hospital emergency，Xiangtan Central Hospital，Hunan Xiangtan 411100，China
- Publication Type:Journal Article
- Keywords:
full process pharmaceutical services;
DRG;
clinical pharmacist;
drug cost control;
complex network analysis
- From:
China Pharmacy
2024;35(17):2136-2141
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To optimize drug treatment plans for patients in cardiovascular FM35 disease group using full-process pharmaceutical services， and achieve the goals of ensuring patient medication safety and controlling drug costs. METHODS Overall 213 patients in the cardiovascular FM35 disease group who were discharged from July to August 2023 were selected as control group； all medical orders were screened and complex network analysis and drug evaluation standards of our hospital were used to establish an optimized treatment drug library； 83 FM35 patients who newly admitted to the cardiovascular department in September 2023 were selected as intervention group； a model of policy promotion-treatment plan intervention was established and applied to provide full process pharmaceutical services to patients. The treatment cost， length of stay and outcome were analyzed and compared between 2 groups. RESULTS Through the full process pharmaceutical services provided by clinical pharmacists， compared with the control group， the total hospitalization cost， drug cost， drug proportion， and case proportion of medical insurance settlement amount in the intervention group significantly decreased （P＜0.05）. The median length of hospital stay in the intervention group was shortened by 1 d， and the discharge improvement outcome rates of both groups of patients were ≥99%. CONCLUSIONS Clinical pharmacists can effectively improve the efficiency of medical services and save the medical costs through full-process pharmaceutical services， meanwhile ensuring medical quality and safety. This can effectively assist in the smooth implementation of DRGs.
